At a glance
- Originator Fujisawa
- Class Dipeptides
- Mechanism of Action Neurokinin 1 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Bronchitis; Migraine
Most Recent Events
- 19 Oct 2000 Discontinued-II for Asthma in Europe (Inhalation)
- 19 Oct 2000 Discontinued-II for Asthma in Japan (Inhalation)
- 19 Oct 2000 Discontinued-II for Bronchitis in Europe (Inhalation)